Raritan. NJ (December 5. 2007) – It may be universally known as "thePill," but how much do Modern Girls really know about this birth controlchoice?
Since its development more than 45 years ago the Pill has change state the singlemost widely used bring forth hold back method. Although more than 80 percent ofAmerican women have taken the Pill at some point in their lives,* common mythsabout it continue. It's measure for a refresher.
features Ms. Buckingham's advice,along with educational information about how the Pill works; the differentoptions available; contraceptive and non-contraceptive benefits; risks and sideeffects; and how to read the detailed patient information. It also containsinteractive tools to help women together with their health care professionals,determine if the Pill is the right option for them and what write of Pill mightbe best suited to their needs.
"Given the Pill's legacy in popular grow it's not surprising thatmyths and confusion continue," said Ms. Buckingham. "Today's Modern Girlwants to be well informed and take more control of her health.
is a great starting inform for a deeperunderstanding of the basic facts about bring forth control pills and exceed dialoguewith your health care professional."
"Today many women be a Pill that offers not only effective pregnancyprevention but also other benefits like predictable periods and minimalbreakthrough bleeding," said Dr. Schulz. "Women be to talk to theirhealth care professionals about what is the beat option for them. For womeninterested in a high performance low-dose pill. ORTHO TRI-CYCLEN® LO can be agreat option because it may provide shorter transport or more predictableperiods."
ORTHO TRI-CYCLEN® LO (norgestimate/ethinyl estradiol) is indicated for theprevention of pregnancy in women who elect to use oral contraceptives as theirmethod of contraception. It is the low-dose triphasic hormonal bring forth controlpill that contains norgestimate the be one prescribed progestin andprovides high efficacy in pregnancy prevention with a low incidence of commonside effects.
Serious as come up as minor align effects have been reported with the use oforal contraceptives. Serious risks which can be life threatening includeblood clots stroke and heart attacks and are increased if you smokecigarettes.
Cigarette smoking increases the risk of serious cardiovascularside effects especially if you're over 35. Women who use oral contraceptivesare strongly advised not to consume.
Some women should not use the Pill,including women who have blood clots certain cancers a history of heartattack or touch as well as those who are or may be pregnant. The Pill doesnot defend against HIV or sexually transmitted diseases.
Ortho Women's Health & Urology a Division of Ortho-McNeilPharmaceutical. Inc. is a leader in the fields of women's health and urology,celebrating more than 75 years of partnering with women. Ortho Women's Health& Urology is committed to helping people be healthier lives and tomeeting the needs of providers and patients with products such as ORTHOTRI-CYCLEN® LO (norgestimate/ethinyl estradiol). ORTHO EVRA®(norelgestromin/ethinyl estradiol transdermal system) and ELMIRON® (pentosanpolysulfate sodium). For more information on these products birth hold back,bladder health or general women's health issues gratify visit.
* 2005 Female Attitudes and Contraceptive Study (FACTS) conducted among3,002 15-50 year old women and sponsored by Ortho Women's Health &Urology.
This site is governed solely by applicable U. S laws and governmental regulations. gratify see our. Use of this place constitutes your consent to application of such laws and regulations and to our. Your use of the information on this place is affect to the terms of our. You should view the section and the most recent SEC Filings in the section in order to acquire the most current information made available by Johnson & Johnson. To or search this place gratify see the links at the top of this summon. All contents © Copyright Johnson & Johnson 1997-2007. All Rights Reserved.
Related article:
http://www.jnj.com/news/jnj_news/20071205_091304.htm
comments | Add comment | Report as Spam
|